The COPE trial has randomized its first kidneys to be included into the trial. The COPE trial is looking to two different aspects of kidney perfusion. First of all it copmpares continuous kidney perfusion with our Kidney Assist with the difference that one branch contains oxygenated perfused kidneys and the other non-oxygenated.
Another workpackage of the COPE looks at the difference between end-ischemic, oxygenated perfusion and standard cold storage. In both workpackages our Kidney Assist device is involved.
Read more about the first inclusion and the rest of the COPE trial here: http://www.cope-eu.org/cope-home/container3/news-and-events-1/first-pomp-kidney-randomised